# Tranexamic Acid in Surgery of Advanced Ovarian Cancer

> **NCT00740116** · PHASE4 · COMPLETED · sponsor: **Preben Kjolhede, MD, professor** · enrollment: 100 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** 0.9% NaCl solution

## Key facts

- **NCT ID:** NCT00740116
- **Lead sponsor:** Preben Kjolhede, MD, professor
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740116, "Tranexamic Acid in Surgery of Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00740116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*